JSC Grindeks hereby informs that on 2 November 2010 it has received a notification from JSC “Pharmstandard” on the alienation of the ownership of 11.38% shares of the JSC Grindeks.

Further information:

Laila Kļaviņa
Head of the Communications Department JSC Grindeks
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
E-mail: laila.klavina@grindeks.lv

Notification from JSC "Pharmstandard" (263 KB)